Skip to content

Net margin at other companies

Merck & Co. logo
Merck & Co.MRK
13.6%-13.7pp
Delcath Systems logo
Delcath SystemsDCTH
1.5%+0.8pp
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
-123.9%-28.4pp
Immunome logo
ImmunomeIMNM
-5,593.8%-11,284pp
Arcus Biosciences logo
Arcus BiosciencesRCUS
-156.4%-47.5pp
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-606.2%-212pp

Other financials

Income statement

See full
Revenue$1.7M
Gross profit$1.3M
Operating income-$28.6M-283%
Net income-$26.6M-244%
EPS (diluted)-$0.27-145%

Balance sheet

See full
Cash & equivalents$2.6M+2,350,466%
Total equity$35.3M-1.0%
Total assets$100.7M+10.1%

Cash flow

See full
Operating cash flow-$3.8M-179%

Valuation

See full
Market cap$60.45M-74.7%

Returns & leverage

See full
Return on equity-119.9%+46.7pp
Current ratio0.5×+0.1×